Effects of integrins and integrin αvβ3 inhibitor on angiogenesis in cerebral ischemic stroke

Abstract

Integrins such as αvβ3, α5β1 play a key role in angiogenesis regulation, invasion and metastasis, inflammation, wound healing, etc. The up-regulation of integrin αvβ3 after cerebral ischemic stroke can promote angiogenesis, which in turn improves functional recovery. In addition, the integrin αvβ3 inhibitor can block the blood-brain barrier (BBB) leakage induced by vascular endothelial growth factor (VEGF) and also can reduce inflammatory reaction, decrease the deposition of fibrinogen. Other studies showed that integrin αvβ3 is not essential in revascularization. Therefore, the effect of integrin αvβ3 in the whole process of brain function recovery merits further study.

Keywords

integrin αvβ3 / cerebral ischemic stroke / vascular endothelial growth factor / cyclo [Arg-Gly-Asp-D-Phe-Val]

References

[1] ChenJ, ChoppM. Neurorestorative treatment of stroke: cell and pharmacological approaches. NeuroRx, 2006, 3(4): 466-473

[2] FanY, YangGY. Therapeutic angiogenesis for brain ischemia: a brief review. J Neuroimmune Pharmacol, 2007, 2(3): 284-289

[3] BeckH, PlateKH. Angiogenesis after cerebral ischemia. Acta Neuropathol, 2009, 117(5): 481-496

[4] IngberDE, FolkmanJ. Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix. J Cell Biol, 1989, 109(1): 317-330

[5] LeeTH, SengS, LiH, et al.. Integrin regulation by vascular endothelial growth factor in human brain microvascular endothelial cells: role of alpha6beta1 integrin in angiogenesis. J Biol Chem, 2006, 281(52): 40450-40460

[6] RiopelM, StuartW, WangR. Fibrin improves beta (INS-1) cell function, proliferation and survival through integrin alphavbeta3. Acta Biomater, 2013, 9(9): 8140-8148

[7] BoissetJC, ClapesT, Van Der LindenR, et al.. Integrin alphaIIb (CD41) plays a role in the maintenance of hematopoietic stem cell activity in the mouse embryonic aorta. Biol Open, 2013, 2(5): 525-532

[8] HynesRO. Integrins: bidirectional, allosteric signaling machines. Cell, 2002, 110(6): 673-687

[9] SchotteliusM, LauferB, KesslerH, et al.. Ligands for mapping alphavbeta3-integrin expression in vivo. Acc Chem Res, 2009, 42(7): 969-980

[10] IngberDE, FolkmanJ. How does extracellular matrix control capillary morphogenesis?. Cell, 1989, 58(5): 803-805

[11] GotwalsPJ, Chi-RossoG, LindnerV, et al.. The alpha1beta1 integrin is expressed during neointima formation in rat arteries and mediates collagen matrix reorganization. J Clin Invest, 1996, 97(11): 2469-2477

[12] DesgrosellierJS, ChereshDA. Integrins in cancer. Biological implications and therapeutic opportunities. Nat Rev Cancer, 2010, 10(1): 9-22

[13] BrooksPC, MontgomeryAM, RosenfeldM, et al.. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell, 1994, 79(7): 1157-1164

[14] BrooksPC, StrömbladS, KlemkeR, et al.. Antiintegrin alpha_v beta_3 blocks human breast cancer growth and angiogenesis in human skin. J Clin Invest, 1995, 96(4): 1815-1822

[15] WangJ, WangL, XiaB, et al.. BSP gene silencing inhibits migration, invasion, and bone metastasis of MDA-MB-231BO human breast cancer cells. PLoS One, 2013, 8(5): e62936

[16] LinSA, PatelM, SureschD, et al.. Quantitative longitudinal imaging of vascular inflammation and treatment by Ezetimibe in apoE mice by FMT using new optical imaging biomarkers of cathepsin activity and alpha(v)beta(3) integrin. Int J Mol Imaging, 2012, 2012: 189254

[17] MargadantC, SonnenbergA. Integrin-TGF-beta crosstalk in fibrosis, cancer and wound healing. EMBO Rep, 2010, 11(2): 97-105

[18] QuinnMJ, ByzovaTV, QinJ, et al.. Integrin alphaIIbbeta3 and its antagonism. Arterioscler Thromb Vasc Biol, 2003, 23(6): 945-952

[19] NikolopoulosSN, BlaikieP, YoshiokaT, et al.. Integrin beta4 signaling promotes tumor angiogenesis. Cancer Cell, 2004, 6(5): 471-483

[20] DittmarM, KiourkenidisG, HornM, et al.. Cerebral ischemia, matrix metalloproteinases, and TNF-alpha: MMP inhibitors may act not exclusively by reducing MMP activity. Stroke, 2004, 35(7): e338-e340

[21] AdhamiF, LiaoG, MorozovYM, et al.. Cerebral ischemia-hypoxia induces intravascular coagulation and autophagy. Am J Pathol, 2006, 169(2): 566-583

[22] del ZoppoG, MilnerR. Integrin-matrix interactions in the cerebral microvasculature. Arterioscler Thromb Vasc Biol, 2006, 26(9): 1966-1975

[23] FukudaS, FiniCA, MabuchiT, et al.. Focal cerebral ischemia induces active proteases that degrade microvascular matrix. Stroke, 2004, 35(4): 998-1004

[24] MilnerR, HungS, ErokwuB, et al.. Increased expression of fibronectin and the a5b1 integrin in angiogenic cerebral blood vessels of mice subject to hypobaric hypoxia. Mol Cell Neurosci, 2008, 38(1): 43-52

[25] MahabeleshwarGH, FengW, ReddyK, et al.. Mechanisms of integrin-vascular endothelial growth factor receptor cross-activation in angiogenesis. Circ Res, 2007, 101(6): 570-580

[26] GrottaJ, JacobsT, KoroshetzW, et al.. Stroke program review group: an interim report. Stroke, 2008, 39(4): 1364-1370

[27] ClarkeDN, Al AhmadA, LeeB, et al.. Perlecan Domain V induces VEGf secretion in brain endothelial cells through integrin alpha5beta1 and ERK-dependent signaling pathways. PLoS One, 2012, 7(9): e45257

[28] EmingSA, BrachvogelB, OdorisioT, et al.. Regulation of angiogenesis: wound healing as a model. Prog Histochem Cytochem, 2007, 42(3): 115-170

[29] DietrichT, OnderkaJ, BockF, et al.. Inhibition of inflammatory lymphangiogenesis by integrin alpha5 blockade. Am J Pathol, 2007, 171(1): 361-372

[30] NaikMU, MousaSA, ParkosCA, et al.. Signaling through JAM-1 and alphavbeta3 is required for the angiogenic action of bFGF: dissociation of the JAM-1 and alphavbeta3 complex. Blood, 2003, 102(6): 2108-2114

[31] BergersG, BrekkenR, McMahonG, et al.. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol, 2000, 2(10): 737-744

[32] PerruzziCA, de FougerollesAR, KotelianskyVE, et al.. Functional overlap and cooperativity among alphav and beta1 integrin subfamilies during skin angiogenesis. J Invest Dermatol, 2003, 120(6): 1100-1109

[33] BrooksPC, MontgomeryMP, RosenfeldM, et al.. Integrin avh3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell, 1994, 79(7): 1157-1164

[34] HiguchiT, BengelFM, SeidlS, et al.. Assessment of alphavbeta3 integrin expression after myocardial infarction by positron emission tomography. Cardiovasc Res, 2008, 78(2): 395-403

[35] BeckH, AckerT, WiessnerC, et al.. Expression of angiopoietin-1, angiopoietin-2, and tie receptors after middle cerebral artery occlusion in the rat. Am J Pathol, 2000, 157(5): 1473-1483

[36] HayashiT, NoshitaN, SugawaraT, et al.. Temporal proWle of angiogenesis and expression of related genes in the brain after ischemia. J Cereb Blood Flow Metab, 2003, 23(2): 166-180

[37] MartiHJ, BernaudinM, BellailA, et al.. Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am J Pathol, 2000, 156(3): 965-976

[38] LiuHM. Neovasculature and blood-brain barrier in ischemic brain infarct. Ada Neuropaihol (Bed), 1988, 75(4): 422-426

[39] KrupinskiJ, KaluzaJ, KumarP, et al.. Role of angiogenesis in patients with cerebral ischemic stroke. Stroke, 1994, 25(9): 1794-1798

[40] PlowEF, HaasTA, ZhangL, et al.. Ligand binding to integrins. J Biol Chem, 2000, 275(29): 21785-21788

[41] LiL, LiuF, Welser-AlvesJV, et al.. Upregulation of fibronectin and the alpha5beta1 and alphavbeta3 integrins on blood vessels within the cerebral ischemic penumbra. Exp Neurol, 2012, 233(1): 283-291

[42] OkadaY, CopelandBR, HamannGF, et al.. Integrin alphavbeta3 is expressed in selected microvessels after focal cerebral ischemia. Am J Pathol, 1996, 149(1): 37-44

[43] WeiL, ErinjeriJP, RovainenCM, et al.. Collateral growth and angiogenesis around cortical stroke. Stroke, 2001, 32(9): 2179-2184

[44] LiL, WelserJV, MilnerR, et al.. Absence of the alpha v beta 3 integrin dictates the time-course of angiogenesis in the hypoxic central nervous system: accelerated endothelial proliferation correlates with compensatory increases in alpha 5 beta 1 integrin expression. J Cereb Blood Flow Metab, 2010, 30(5): 1031-1043

[45] ChoiH, PhiJH, PaengJC, et al.. Imaging of integrin alpha(V)beta(3) expression using (68)Ga-RGD positron emission tomography in pediatric cerebral infarct. Mol Imaging, 2013, 12(4): 213-217

[46] TomanekRJ, SchattemanGC. Angiogenesis: new insights and therapeutic potential. Anat Rec, 2000, 261(3): 126-135

[47] ByzovaTV, GoldmanCK, PamporiN, et al.. A mechanism for modulation of cellular responses to VEGF: activation of the integrins. Mol Cell, 2000, 6(4): 851-860

[48] ZuckerS, MirzaH, ConnerCE, et al.. Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: conversion of prothrombin to thrombin results in progelatinase A activation and cell proliferation. Int J Cancer, 1998, 75(5): 780-786

[49] AbumiyaT, LuceroJ, HeoJH, et al.. Activated microvessels express vascular endothelial growth factor and integrin alpha(v)beta3 during focal cerebral ischemia. J Cereb Blood Flow Metab, 1999, 19(9): 1038-1050

[50] VeronD, VillegasG, Aggarwal, et al.. Acute podocyte vascular endothelial growth factor (VEGF-A) knockdown disrupts alphaVbeta3 integrin signaling in the glomerulus. PLoS One, 2012, 7(7): e40589

[51] SengerDR, ClaffeyKP, BenesJE, et al.. Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins. Proc Natl Acad Sci U S A, 1997, 94(25): 13612-13617

[52] LeeB, ClarkeD, Al AhmadA, et al.. Perlecan domain V is neuroprotective and pro-angiogenic following ischemic brain stroke in rodents. JCI, 2001, 121(8): 3005-3023

[53] AndersonCR, HuX, ZhangH, et al.. Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent. Invest Radiol, 2011, 46(4): 215-224

[54] BurnettCA, XieJ, QuijanoJ, et al.. Synthesis, in vitro, and in vivo characterization of an integrin αvβ3-targeted molecular probe for optical imaging of tumor. Bioorg Med Chem, 2005, 13(11): 3763-3771

[55] HayashiT, AbeK, Suzuki, et al.. Rapid induction of vascular endothelial growth factor gene expression after transient middle cerebral artery occlusion in rats. Stroke, 1997, 28(10): 2039-2044

[56] KrumJM, ManiN, Rosenstein, et al.. Angiogenic and astroglial responses to vascular endothelial growth factor administration in adult rat brain. Neuroscience, 2002, 110(4): 589-604

[57] ShimamuraN, MatchettG, YatsushigeH, et al.. Inhibition of integrin alphavbeta3 ameliorates focal cerebral ischemic damage in the rat middle cerebral artery occlusion model. Stroke, 2006, 37(7): 1902-1909

[58] ShimamuraN, MatchettG, SolarogluI, et al.. Inhibition of integrin alphavbeta3 reduces blood-brain barrier breakdown in focal ischemia in rats. J Neurosci Res, 2006, 84(8): 1837-1847

[59] SchachtrupC, LuP, JonesLL, et al.. Fibrinogen inhibits neurite outgrowth via beta3 integrin-mediated phosphorylation of the EGF receptor. Proc Natl Acad Sci USA, 2007, 104(28): 11814-11819

[60] RyuJK, DavalosD, AkassoglouK. Fibrinogen signal transduction in the nervous system. J Thromb Haemost, 2009, 7(Suppl1): 151-154

[61] WeerasingheD, McHughKP, RossFP, et al.. A role for the alphavbeta3 integrin in the transmigration of monocytes. J Cell Biol, 1998, 142(2): 595-607

[62] BishopGG, McPhersonJA, SandersJM, et al.. Selective alpha(v)beta(3)-receptor blockade reduces macrophage infiltration and restenosis after balloon angioplasty in the atherosclerotic rabbit. Circulation, 2001, 103(14): 1906-1911

[63] AdhamiF, YuD, YinW, et al.. Deleterious effects of plasminogen activators in neonatal cerebral hypoxia-ischemia. Am J Pathol, 2008, 172(6): 1704-1716

[64] KiesslingJW, CineseDB, HigaziAA, et al.. Inhibition of integrin alphavbeta3 prevents urokinase plasminogen activator-mediated impairment of cerebrovasodilation after cerebral hypoxia/ischemia. Am J Physiol Heart Circ Physiol, 2009, 296(3): H862-867

[65] ZhangL, ZhangZG, ZhangC, et al.. Intravenous administration of a GPIIb/IIIa receptor antagonist extends the therapeutic window of intraarterial tenecteplase tissue plasminogen activator in a rat stroke model. Stroke, 2004, 35(12): 2890-2895

[66] KroonME, KoolwijkP, van der VechtB, et al.. Urokinase receptor expression on human microvascular endothelial cells is increased by hypoxia: implications for capillary-like tube formation in a fibrin matrix. Blood, 2000, 96(8): 2775-2783

[67] LeventhalC, RaWiS, RaWiD, et al.. Endothelial trophic support of neuronal production and recruitment from the adult mammalian subependyma. Mol Cell Neurosci, 1999, 13(6): 450-464

[68] HarriganMR, EnnisSR, MasadaT, et al.. Intraventricular infusion of vascular endothelial growth factor promotes cerebral angiogenesis with minimal brain edema. Neurosurgery, 2002, 50(3): 589-598

[69] LiL, JVW, MilnerR, et al.. Absence of the alpha v beta 3 integrin dictates the time-course of angiogenesis in the hypoxic central nervous system: accelerated endothelial proliferation correlates with compensatory increases in alpha 5 beta 1 integrin expression. J Cereb Blood Flow Metab, 2010, 30(5): 1031-1043

[70] ZhangZG, ZhangL, JiangQ, et al.. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest, 2000, 106(7): 829-838

[71] KayaD, Gursoy-OzdemirY, YemisciM, et al.. VEGF protects brain against focal ischemia without increasing blood—brain permeability when administered intracerebroventricularly. J Cereb Blood Flow Metab, 2005, 25(9): 1111-1118

[72] SilvaR, D’AmicoG, Hodivala-DilkeKM, et al.. Integrins: the keys to unlocking angiogenesis. Arterioscler Thromb Vasc Biol, 2008, 28(10): 1703-1713

[73] MaYQ, QinJ, WuC, et al.. Kindlin-2 (Mig-2): a co-activator of beta3 integrins. J Cell Biol, 2008, 181(3): 439-446

[74] MullamithaSA, TonNC, ParkerGJ, et al.. Phase I evaluation of a fully human anti-alphav integrin monoclonal antibody (CNTO 95) in patients with advanced solid tumors. Clin Cancer Res, 2007, 13(7): 2128-2135

[75] HaubnerR, WeberWA, BeerAJ, et al.. Noninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD. PLoS Med, 2005, 2(3): e70

[76] HaubnerR, KuhnastB, MangC, et al.. [18F]Galacto-RGD: synthesis, radiolabeling, metabolic stability, and radiation dose estimates. Bioconjug Chem, 2004, 15(1): 61-69

[77] HaubnerR, WesterHJ. Radiolabeled tracers for imaging of tumor angiogenesis and evaluation of anti-angiogenic therapies. Curr Pharm Des, 2004, 10(13): 1439-1455

[78] LaitinenI, SarasteA, WeidlE, et al.. Evaluation of alphavbeta3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice. Circ Cardiovasc Imaging, 2009, 2(4): 331-338